Heterocyclic compounds
AssigneeNippon Shinyaku Co., Ltd.
InventorsKenji Kuwabara, Tomiyoshi Aoki
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Shinyaku Co., Ltd.
InventorsKenji Kuwabara, Tomiyoshi Aoki
Estimating the term…
The present invention provides a preventive or therapeutic agent for hyperlipidemia, comprising as an active ingredient a heterocyclic compound of the formula [1], or a pharmaceutically acceptable salt thereof: R1-Het-D-E [1] wherein: R1 is optionally substituted aryl or aromatic heterocyclic group, Het is a divalent aromatic heterocyclic group, D is alkylene, alkenylene, alkynylene, or the like, and E is carboxy, or the like, and novel compounds among the heterocyclic compounds of the formula [1] above, which has blood triglyceride lowering effect, LDL-C lowering effect, and blood glucose lowering effect and blood insulin lowering effect, or HDL-C increasing effect or atherogenic index lowering effect all together, and hence is useful in the prevention or treatment of hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity, and the like.
A preventive or therapeutic agent for hyperlipidemia, comprising as an active ingredient a heterocyclic compound of the formula [1], or a pharmaceutically acceptable salt thereof:
17 (Amended). A heterocyclic compound of the formula [1] as set forth in claim 1, or a pharmaceutically acceptable salt thereof, with the proviso that a compound of the formula [1] wherein D is alkylene having 1 to 6 carbon atoms, E is a group of the formula [4] wherein Y is oxygen, is excluded.
The heterocyclic compound of claim 17, wherein D is alkylene, alkenylene or alkynylene having 3-10 carbon atoms, or a pharmaceutically acceptable salt thereof.
The heterocyclic compound of claim 17, wherein Het is a divalent aromatic heterocyclic group of the formula [5]:
The heterocyclic compound of claim 17, wherein Het is a divalent aromatic heterocyclic group of the formula [5]:
23 (Amended). The heterocyclic compound of claim 21, wherein R1 is phenyl optionally substituted by one to two groups selected from alkyl, halogen and alkoxy;
25 (Amended). The heterocyclic compound of claim 23, wherein R1 is phenyl optionally substituted by one to two groups selected from alkyl, halogen and alkoxy;
26 (Amended). The heterocyclic compound of claim 17, which is selected from the group consisting of compounds (1) to (10) below:
(Added) A heterocyclic compound selected from the group consisting of compounds (1) to (11) below:
28 (Added). The heterocyclic compound of claim 27 selected from the group consisting of compounds (1) to (6) below:
Dependencies are inferred from the claim text.